Hofmann H, Bon C
Biochemistry. 1987 Feb 10;26(3):772-80. doi: 10.1021/bi00377a018.
In this paper, we show that the procoagulant action of Bothrops atrox venom is due in part to a protein component that activates prothrombin. The venom prothrombin activator was purified by ion-exchange chromatography and gel filtration. It was separated from a protease by affinity chromatography in a p-aminobenzamidine-CH-Sepharose column. It is a protein of about Mr 70,000, consisting of a single polypeptide chain. We have studied the kinetics of activation of prothrombin under different experimental conditions. The prothrombin activator from B. atrox venom is insensitive to reagents of serine and thiol proteases but is inactivated by ion chelators and by various divalent ions. These results suggest that it is a metalloenzyme. The prothrombin activator from B. atrox venom is inactive on the chromogenic substrates S-2337 and S-2238, and it is selective for prothrombin since it does not act on other blood coagulation factors such as fibrinogen and factor X. We have also studied the pattern of peptide cleavages produced in the human prothrombin molecule during the activation by the activator from B. atrox venom and compared it to that obtained with ecarin, a prothrombin activator from Echis carinatus venom. In the presence of thrombin inhibitors, e.g., hirudin, we found that the activators from B. atrox venom and ecarin act in a similar, or identical, manner by producing a thrombin intermediate, meizothrombin. In the absence of thrombin inhibitors, several peptides are generated, and alpha-thrombin is produced as a consequence of meizothrombin action.
在本文中,我们表明,矛头蝮蛇毒的促凝作用部分归因于一种能激活凝血酶原的蛋白质成分。通过离子交换色谱法和凝胶过滤法对蛇毒凝血酶原激活剂进行了纯化。在对氨基苯甲脒-CH-琼脂糖柱上通过亲和色谱法将其与一种蛋白酶分离。它是一种分子量约为70,000的蛋白质,由一条单一多肽链组成。我们研究了在不同实验条件下凝血酶原激活的动力学。矛头蝮蛇毒的凝血酶原激活剂对丝氨酸和巯基蛋白酶的试剂不敏感,但会被离子螯合剂和各种二价离子灭活。这些结果表明它是一种金属酶。矛头蝮蛇毒的凝血酶原激活剂对生色底物S-2337和S-2238无活性,并且它对凝血酶原具有选择性,因为它不作用于其他血液凝固因子,如纤维蛋白原和因子X。我们还研究了在被矛头蝮蛇毒激活剂激活过程中,人凝血酶原分子产生的肽段裂解模式,并将其与锯鳞蝰蛇毒的凝血酶原激活剂伊卡林所产生的模式进行了比较。在存在凝血酶抑制剂,如水蛭素的情况下,我们发现矛头蝮蛇毒和伊卡林的激活剂通过产生凝血酶中间体——中间凝血酶,以相似或相同的方式起作用。在不存在凝血酶抑制剂的情况下,会产生几种肽段,并且由于中间凝血酶的作用而产生α-凝血酶。